Product Information
CYCLOSPORINE 25 MG CAPSULE is a generic product labeled by Apotex Corp., priced at $2.5957 per EA under NDC 60505013300. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 9, 2002. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Apotex Corp.NDC
60505013300
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA065040FDA Approved
5/9/2002
TE Code
AB2
On Market Since
5/29/2002
Pharmacological Classes
Price Statistics
The NADAC for CYCLOSPORINE 25 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 87.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5957 per EA |
|---|---|
| All-time high | $2.8796 (Feb 11, 2026) |
| All-time low | $1.3882 (Nov 28, 2013) |
| 52-week high | $2.8796 |
| 52-week low | $2.5776 |
| Median price | $2.2248 |
| Average price | $2.1794 |
| Largest weekly change | +34.2% (Mar 18, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyclosporine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calcineurin Inhibitor Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYCLOSPORINE 25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE 25 MG CAPSULE, manufactured by Apotex Corp., is $2.5957 per EA (NDC 60505013300), effective Sep 30, 2026.
How has the price of CYCLOSPORINE 25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CYCLOSPORINE 25 MG CAPSULE has risen 87.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CYCLOSPORINE 25 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CYCLOSPORINE 25 MG CAPSULE has ranged from a low of $1.3882 (Nov 28, 2013) to a high of $2.8796 (Feb 11, 2026), with a median of $2.2248 per EA.
Are there cheaper alternatives to CYCLOSPORINE 25 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOSPORINE MODIFIED 25 MG, is $0.3138 per EA — about 88% below CYCLOSPORINE 25 MG CAPSULE.
Who manufactures CYCLOSPORINE 25 MG CAPSULE?
CYCLOSPORINE 25 MG CAPSULE (NDC 60505013300) is labeled by Apotex Corp., and CMS classifies it as a generic product.